Related Experiment Video
Updated: Oct 15, 2026

Protein Target Prediction and Validation of Small Molecule Compound
Published on: February 23, 2024
Representation-aware conformal prediction for reliable uncertainty quantification in drug-target affinity
Xinya Li1, Yaxin Zhang1, Ximin Zeng1
1Department of Mathematics, School of Mathematics and Computer Sciences, Nanchang University, Nanchang 330031, China.
Motivation:
Quantifying predictive uncertainty is essential for computational drug discovery to reduce experimental costs and false positives. However, most drug-target affinity (DTA) models focus on improving prediction accuracy without reliable uncertainty estimates.
Results:
We propose RCP-DTA, a representation-aware conformal prediction framework that constructs adaptive prediction intervals based on feature similarity. By constructing local calibration sets, our approach generates sample-specific prediction intervals that achieve empirical coverage close to the nominal confidence level. To enhance representation quality, RCP-DTA employs a cross-modal architecture that integrates pre-trained sequence representations and structural information. Binding site context is incorporated via virtual pocket feedback to enhance residue representations, followed by gated fusion for adaptive integration of sequence and structural modalities. Evaluations across multiple DTA benchmark datasets demonstrate that RCP-DTA achieves competitive affinity prediction performance while providing reliable uncertainty quantification.
Availability:
Code and data are available at: https://github.com/Lee515628/RCP-DTA.
Supplementary Information:
Supplementary data are available at Bioinformatics online.
Related Concept Videos
Quantitative Aspects of Drug-Receptor Interaction
Uncertainty: Overview
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Physiological Pharmacokinetic Models: Assumption with Protein Binding
